Cambium Biomaterials, Inc. — Form D
Cambium Biomaterials, Inc. of El Segundo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-04. The offering totals $101.4M, of which $94.4M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-12-04
- Form: D
- Accession: 0001883516-25-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $101.4M
- Amount sold: $94.4M
- Remaining: $7.0M
- Investors: 33
- Date of first sale: 2025-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-565703
Issuer
- Name: Cambium Biomaterials, Inc.
- CIK: 0001883516
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 111 Maryland Street, El Segundo, CA, 90245
- Phone: (415) 878-3752
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Francisco Gimenez | Director | Minneapolis, MN |
| Christopher Pederson | Director | El Segundo, CA |
| Brett Schneider | Director | El Segundo, CA |
| Simon Waddington | Director | El Segundo, CA |
| Tim Gardner | Executive Officer | El Segundo, CA |
| James Griffin | Executive Officer | El Segundo, CA |
| Stephan Herrera | Executive Officer | El Segundo, CA |
| Nic Madren | Executive Officer | El Segundo, CA |
| Simon Waddington | Executive Officer | El Segundo, CA |
| Stephan Herrera | Director | El Segundo, CA |
| Eliot Pence | Executive Officer | Mojave, CA |
| ANDREW GUENTHNER | Executive Officer | BERKELEY, CA |
Other filings by this issuer (2)
More